Home » HIV-AIDS » Page 2
Tag:

HIV-AIDS

Health

Found 234 HIV sufferers in Rembang in the last 2.5 years

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Rembang – found 234 people with Human Immunodeficiency Virus (HIV) in Rembang in the last 2.5 years, namely in 2023, 2024 and mid -May 2025. The details were in 2023 there were 139 cases, 2024 there were 130 cases, and until May 2025 found 65 cases.


Six people found this year, are known to have died. Their condition is in an advanced stage, the immune is very low and many organs in the body are damaged.

Head of the Rembang Regency Health Office (Dinkes) Dr. Ali Syofi’i ‘when confirmed by RMOLJateng, Tuesday (07/08) said that the Rembang Health Office routinely examined the key population to monitor the spread of HIV cases. The key population in question includes visitors to coffee shops, men like men (LSL), cafes and dim stalls.

Ali added, the DHO recorded, until May this year, 65 HIV cases had been found. Of this number 6 (six) of them died.

While sufferers in 2024, 138 cases were recorded. If you look at the addition rates in each month, the number of findings of 2024 and 2025 tends to be the same. An average of 10-12 cases per month.

The most recorded findings in Rembang, Lasem, and Kragan Districts.

“The Health Office is routinely implementing mobile clinic and examination of the key population every three months. So every puskesmas if you have hotspot. Meaning hotspot That ‘can place gather it key population, he carried out mobile clinic That, “explained Ali Syofi’i.

When implementing mobile clinicofficers conduct socialization about HIV and other diseases. In addition, there are also HIV and syphilis examinations. It does not determine the inspection target.

“It depends, so it doesn’t have to be how many people. How much, yes, that’s it. We continue to go around in a coffee shop or cafe,” he said.

The target includes women of sex workers (WPS), men, men, waria, to the Citizens of the Baby (WBP).

“WPS, then LSL, we have carried out transvestites. The key population ‘can That. Continue to WBP, residents of the Corrections in Detention Center (Detention Center – red). We have carried out. Every three months, we have carried out in the key population, “he explained.

Ali Syofi’i added, in the last examination, his party did not find the addition of new cases. Still all negative. Likewise, syphilis is also nothing positive. Found 234 HIV sufferers in Rembang in the last 2.5 years

0 comments
0 FacebookTwitterPinterestEmail
Health

HIV Funding Cuts: Activists Fight Back to Save Lives

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

HIV Advocates Mobilize as Federal Funding Cuts Threaten Progress

Table of Contents

As federal funding for HIV programs faces drastic cuts, advocates and community leaders are mobilizing to protect decades of progress in combating the epidemic. The proposed budget reductions threaten vital services, notably in the Southern U.S., where over half of all new HIV diagnoses occur, and among low-income individuals who rely on Medicaid for treatment.

The Looming threat to HIV Programs

The Trump administration‘s actions, including clawing back billions in public health grants and proposing significant cuts to Medicaid, have sparked widespread concern among HIV advocates. These cuts jeopardize access to testing, outreach, and treatment, possibly reversing gains made in recent years. According to a KFF analysis, the administration’s proposed budget for HIV prevention represents a 78% reduction compared with fiscal year 2025.

Did You Know? In 2023, non-governmental funders contributed $284 million toward HIV efforts in the U.S., a fraction of the approximately $16 billion in annual federal funding.

Community Response: Forming “Voltron”

In the face of these challenges, HIV advocates are drawing strength from their history of overcoming adversity. Marnina Miller, co-executive director of the Positive Women’s Network, emphasizes the community’s resilience. June Gipson, CEO of My Brother’s Keeper, a Mississippi health care nonprofit, invokes the image of “forming Voltron,” highlighting the need for collective action.

Cedric Sturdevant, founder of Community Health PIER, a nonprofit serving the Mississippi Delta, is urging his colleagues to unite and strategize. He reminds them of the movement’s past triumphs, including overcoming government inaction in the 1980s and addressing disparities in access to treatment in the 1990s and early 2000s.

The Weight of Stigma and the Importance of Holistic Care

Stigma remains a significant barrier to HIV treatment and prevention. Sturdevant’s personal experience underscores the impact of societal attitudes on individuals’ willingness to seek care. Data from the CDC’s in-depth surveys reveal that many peopel living with HIV grapple with unstable housing, food insecurity, depression, and anxiety, highlighting the need for holistic care that addresses these underlying issues.

Community-based interventions, such as those involving Black churches, have proven effective in increasing HIV testing and awareness. Amy Nunn, a public health researcher at Brown University, notes the eagerness of pastors to help combat stigma and promote prevention.

Strategies for Survival and Continued Progress

Researchers and advocates are exploring strategies to mitigate the impact of federal funding cuts. These include partnerships between larger, established HIV organizations and smaller, grassroots groups, as well as increased coordination with churches and nonprofits that provide essential services like food assistance, housing, and mental health care.

Pro tip: Civil society stepping up to provide care outside of government channels is crucial in filling the gaps created by funding cuts.

National groups like AIDS United are seeking corporate and philanthropic support to sustain HIV organizations. However, philanthropic funding cannot fully compensate for the loss of federal dollars. Masen Davis, executive director of Funders Concerned About AIDS, warns that new HIV infections may rise within 18 months due to the cuts.

Despite the challenges, Sturdevant remains steadfast to fight for those who lack the strength to do so themselves. He emphasizes the need to persevere and continue working towards a future where everyone living with HIV has access to the care and support thay need.

The Role of Faith-Based organizations

Faith-based organizations, particularly Black churches, are playing an increasingly important role in HIV prevention and care. These institutions serve as trusted community hubs, providing education, outreach, and support to individuals affected by HIV. Bishop Ronnie Crudup of new Horizon Church international emphasizes the need to ramp up services and integrate HIV care into broader community health initiatives.

How can communities better leverage existing resources to support HIV prevention and treatment?

What innovative strategies can be implemented to combat stigma and promote access to care in underserved areas?

Key HIV statistics in the United States

Here’s a snapshot of the HIV epidemic in the U.S., based on the latest data from the Centers for Disease Control and Prevention (CDC) and other sources:

Metric Value Source
New HIV Infections (2021) 32,100 CDC
People living with HIV (2021) 1.2 million CDC
Percentage of People with HIV Who Know Their Status 87% CDC
Percentage of People with HIV Who are Virally Suppressed 66% CDC
HIV Diagnoses in the South (2021) 52% of all U.S. diagnoses CDC

Evergreen Insights: Understanding the HIV Epidemic

The HIV epidemic in the United States has evolved significantly as its emergence in the 1980s. Initially affecting primarily white, upper- and middle-class gay men, the epidemic has increasingly impacted marginalized communities, particularly black individuals in the South. Factors such as poverty, lack of access to healthcare, and stigma contribute to these disparities.

Advances in antiretroviral therapy (ART) have transformed HIV from a death sentence into a manageable chronic condition.Though,challenges remain in ensuring that everyone living with HIV has access to treatment and achieves viral suppression. Addressing social determinants of health, such as housing, food security, and mental health, is crucial for improving outcomes.

Frequently Asked Questions About HIV

What is HIV and how is it transmitted?
HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system.It is primarily transmitted through unprotected sex, sharing needles, or from mother to child during pregnancy, childbirth, or breastfeeding.
How effective is current HIV treatment?
Current HIV treatment, known as antiretroviral therapy (ART), is highly effective.When taken as prescribed, ART can suppress the virus to undetectable levels, preventing transmission and allowing people with HIV to live long, healthy lives.
what are the main challenges in HIV prevention and care today?
Key challenges include stigma, lack of access to healthcare, social determinants of health (such as poverty and housing instability), and funding cuts to HIV programs.
How can I get tested for HIV?
You can get tested for HIV at your doctor’s office, local health department, community health center, or through home testing kits. The CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once.
What resources are available for people living with HIV?
Numerous resources are available,including medical care,support groups,housing assistance,and financial aid. Organizations like the Ryan white HIV/AIDS Program,local AIDS service organizations,and community health centers can provide assistance.
How does stigma affect people living with HIV?
Stigma can lead to discrimination, isolation, and mental health issues. It can also prevent people from getting tested, seeking treatment, and disclosing their status to others.
What is the role of community-based organizations in addressing HIV?
Community-based organizations play a vital role in providing culturally competent services, reaching marginalized populations, and advocating for policies that support people living with HIV.

Disclaimer: This article provides general data and shoudl not be considered medical advice.consult with a healthcare professional for personalized guidance.

Share this article to raise awareness about the challenges facing HIV programs and the importance of community support. What are your thoughts on the strategies being implemented to combat these challenges? Leave a comment below!


0 comments
0 FacebookTwitterPinterestEmail
Health

Free HIV Testing in Shelby County for National HIV Testing Day

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Free HIV Testing Initiative Launched in Shelby County Amidst Rising Infection Rates

Table of Contents

MEMPHIS,TN – In response to concerning trends in local HIV infection rates,the Shelby County Health Department (SCHD) is providing free HIV testing on Friday,June 27,as part of national HIV Testing Day. The event aims to increase awareness and access to testing, particularly among young adults, who have seen a significant rise in infections. The event will be held on Saturday, June 28, 2025.

Free Testing Event Details

The SCHD will host the event on its front lawn at 814 Jefferson avenue. From 8 a.m. to 3 p.m., attendees can access free HIV testing in the Sexual Health Clinic. The event will also feature food trucks, music, giveaways, free in-home HIV testing kits, health information, and various resources. this initiative is particularly significant for the Mid-South region, where HIV rates are a major concern.

Did You Know? According to the Centers for Disease control and Prevention (CDC), in 2021, 30,635 people in the United States were diagnosed with HIV [[1]].

Shelby County’s HIV Infection Rate

Shelby County faces a significant challenge with HIV. Dr. Michelle Taylor, Director-Health Officer for SCHD, reports that the county has the second-highest HIV infection rate among metropolitan areas in the United states. This alarming statistic underscores the urgent need for increased testing and prevention efforts within the community.

A concerning trend highlighted by Dr. Taylor is the increase in HIV infection rates among young people. Between 2022 and 2023, the infection rate for individuals aged 15 to 19 in Shelby County rose by approximately 50 percent. This sharp increase emphasizes the importance of targeted interventions and education programs for this vulnerable age group.

The importance of Testing

Dr. Taylor emphasizes that increased HIV testing is crucial for addressing these high HIV incidence rates. “Testing is the first step to caring for yourself, whether the results are positive or negative. Together, we can end the HIV epidemic one test at a time,” she stated in a recent news release.

Pro Tip: Regular HIV testing is recommended for sexually active individuals and those who share needles. Early detection and treatment can significantly improve health outcomes and prevent further transmission.

HIV Testing and Treatment Landscape

The fight against HIV has seen significant advancements in recent years. Effective treatments, such as antiretroviral therapy (ART), can help people with HIV live long and healthy lives and prevent the transmission of the virus to others [[2]]. However, access to testing and treatment remains a critical barrier, particularly in communities with high infection rates.

Metric Value
Shelby County HIV Infection Rate 2nd highest in US metropolitan areas
Increase in infection Rate (Ages 15-19, 2022-2023) Approximately 50%
Event date June 28, 2025

What steps can local communities take to further reduce HIV infection rates? How can individuals contribute to raising awareness and promoting regular testing?

Understanding HIV and AIDS

HIV (human immunodeficiency virus) targets the immune system, specifically CD4+ cells, which are crucial for fighting off infections [[3]]. Over time, HIV can lead to AIDS (acquired immunodeficiency syndrome), the most severe phase of HIV infection. AIDS weakens the immune system to the point where it struggles to defend against opportunistic infections and certain cancers.

Early symptoms of HIV infection can include fever, rash, and flu-like symptoms [[2]]. Tho, many people may not experience any symptoms initially, making testing essential for early detection. While there is currently no cure for HIV, consistent use of antiretroviral therapy can effectively manage the virus, allowing individuals to live long and healthy lives.

Frequently asked Questions About HIV

What is HIV?
HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If left untreated, it can lead to AIDS (acquired immunodeficiency syndrome).
How is HIV transmitted?
HIV is primarily transmitted through unprotected sex,sharing needles,syringes,or other drug injection equipment,and from mother to child during pregnancy,childbirth,or breastfeeding.
What are the symptoms of HIV?
Early symptoms can include fever, fatigue, rash, and swollen lymph nodes. However, many people may not experience symptoms for years.
How is HIV diagnosed?
HIV is diagnosed through blood or saliva tests that detect the presence of the virus or antibodies to the virus.
Is there a cure for HIV?
currently, there is no cure for HIV, but effective treatments (antiretroviral therapy) can control the virus and allow people with HIV to live long and healthy lives.
How can I prevent HIV?
Prevention strategies include using condoms during sex, getting tested regularly, avoiding sharing needles, and taking pre-exposure prophylaxis (PrEP) if you are at high risk.

Disclaimer: This article provides general information and should not be considered medical advice. consult with a healthcare professional for personalized guidance and treatment.

Share this article to spread awareness about HIV testing and prevention! What other questions do you have about HIV and AIDS? Let us know in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

FDA Approves HIV Prevention Shot: Twice-Yearly Treatment

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

FDA Approves Lenacapavir: A Twice-Yearly Injection for HIV prevention

Table of Contents



Disclaimer: This article provides information about a medical breakthrough. Consult with a healthcare professional for medical advice and treatment options.

Breaking news: In a landmark decision, the U.S. Food and Drug Administration (FDA) approved lenacapavir on June 18, marking the first-of-its-kind, twice-yearly injectable medication for HIV prevention. This innovative approach offers a new tool in the ongoing effort to combat the HIV epidemic, providing individuals at high risk with a more convenient and potentially more effective prevention method.

A new Era in HIV Prevention

The FDA’s approval of lenacapavir, marketed as Yeztugo, represents a meaningful advancement in HIV prevention. This long-acting injectable is administered just twice a year, offering a stark contrast to the daily oral medications currently used for pre-exposure prophylaxis (PrEP). This new option could transform the landscape of HIV prevention, particularly for individuals who struggle with adherence to daily medication regimens.

Customary anti-HIV treatments have been instrumental in suppressing the virus to undetectable levels, preventing transmission and allowing HIV-negative individuals to maintain their status through PrEP. Though, the reliance on daily pills frequently enough leads to inconsistent adherence, diminishing the effectiveness of these treatments. Lenacapavir circumvents this challenge with its extended-release formula, ensuring sustained protection against HIV infection.

Pro Tip: Consistent use of PrEP medication is key to preventing HIV. Talk to your doctor about the best option for you.

clinical Trial Success

Clinical trials conducted by Gilead Sciences, the developer of lenacapavir, demonstrated remarkable efficacy. The drug showed a 96% effectiveness in protecting cisgender women from HIV infection compared to daily oral PrEP. Among men who have sex with men and gender-diverse individuals, lenacapavir achieved a 100% success rate in preventing HIV acquisition.

Dr. David Ho, a professor of microbiology, immunology, and medicine at Columbia University, hailed lenacapavir as a “huge breakthrough,” emphasizing its potential to significantly curb the HIV epidemic. His pioneering work in combining anti-HIV drugs has been crucial in suppressing the virus and preventing its mutation into resistant strains.

Despite the promising results, advocacy groups and global AIDS organizations have voiced concerns about the accessibility of lenacapavir, particularly considering recent funding cuts to U.S.-supported HIV treatment and prevention programs worldwide.

From Treatment to Prevention: The Lenacapavir story

Lenacapavir initially gained FDA approval in 2022 for treating individuals with HIV who had developed resistance to other antiviral drugs. During its growth, Gilead scientists discovered that lenacapavir possessed unique properties that made it a promising candidate for HIV prevention.These properties include its ability to remain in the body for extended periods and its capacity to interfere with multiple stages of the virus’s replication process.

According to Tomas Cihlar, senior vice president of virology at Gilead, a single injection of lenacapavir demonstrated a “fantastic effect” in protecting non-human primates from HIV acquisition, prompting the company to prioritize its development for prevention.

Jared Baeten, vice president of HIV development at Gilead, noted that the safety standards for preventive drugs are particularly stringent. However, based on extensive pharmacological data, scientific evidence, antiviral activity, and safety profiles from HIV treatment studies, the decision was made in late 2020 to advance lenacapavir into prevention trials.

Did You Know? The global HIV/AIDS response requires an estimated $29.3 billion annually by 2025, according to UNAIDS.UNAIDS estimates

Lenacapavir vs. HIV Vaccine Efforts

While not a vaccine, lenacapavir’s preventive effect is similar. Vaccines stimulate the immune system to recognize and combat pathogens, while lenacapavir maintains circulating drug levels to neutralize any invading virus. This distinction is significant, especially considering the ongoing challenges in developing an effective HIV vaccine over the past four decades.

As Dr. Ho points out, current vaccine candidates have not demonstrated the same level of promise in preventing HIV infection as lenacapavir. The drug offers a new paradigm in HIV prevention, providing a direct and sustained defense against the virus.

Global Access and Manufacturing

To ensure broader access to lenacapavir in resource-limited countries, Gilead Sciences has negotiated royalty-free licensing deals with six generic manufacturers. This initiative aims to facilitate the production of affordable lenacapavir for prevention in 120 low- and middle-income countries.

Despite these efforts, concerns remain about the actual availability of the drug in these regions. Experts like Frost suggest that even with local manufacturing capacity, access may be limited due to disruptions in traditional distribution channels, such as USAID and PEPFAR.

Key Facts About lenacapavir

Feature Description
Type Long-acting injectable medication
Frequency Administered twice a year
Efficacy Up to 100% in clinical trials
Mechanism Interferes with HIV replication
Target Population Individuals at high risk of HIV infection

Evergreen Insights: Understanding HIV Prevention

HIV prevention has evolved significantly sence the discovery of the virus in the early 1980s. Initially, prevention efforts focused on promoting safe sex practices and reducing risky behaviors. The introduction of antiretroviral therapy (ART) revolutionized HIV treatment,enabling people living with HIV to suppress the virus and prevent transmission.

Pre-exposure prophylaxis (PrEP), using daily oral medications, emerged as a highly effective prevention strategy for HIV-negative individuals at risk.Though, adherence to daily regimens has been a persistent challenge. The development of long-acting injectables like lenacapavir represents a new frontier in HIV prevention, offering a more convenient and potentially more effective alternative.

The global HIV/AIDS response requires a multi-faceted approach, including prevention, treatment, and care. Addressing social determinants of health, such as poverty, inequality, and discrimination, is also crucial for reducing HIV incidence and improving the lives of people affected by the virus.

Frequently Asked Questions About Lenacapavir

What are the potential side effects of lenacapavir?

Like all medications, lenacapavir may cause side effects. Clinical trials have evaluated the safety profile of the drug, and healthcare providers can provide detailed information about potential risks and benefits.

How can I access lenacapavir?

Lenacapavir is available by prescription only. Individuals interested in using lenacapavir for HIV prevention should consult with their healthcare provider to determine if it is an appropriate option.

Is lenacapavir a cure for HIV?

No, lenacapavir is not a cure for HIV.It is indeed a prevention method that can significantly reduce the risk of infection.

How does lenacapavir compare to other PrEP options?

Lenacapavir offers the advantage of being a long-acting injectable, requiring administration only twice a year. Other PrEP options typically involve daily oral medications.

What is the cost of lenacapavir?

The cost of lenacapavir may vary depending on insurance coverage and other factors. Contact your healthcare provider or insurance company for more information.

What impact do you think this new HIV prevention method will have on global health? How can we ensure equitable access to lenacapavir for all who need it?

Share this article and join the conversation!

0 comments
0 FacebookTwitterPinterestEmail
Health

Kulonprogo HIV Cases Rise: 19 New Infections Detected

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

HIV-AIDS Cases in Kulonprogo: Understanding the Role of Risky Behaviors

Table of Contents

Kulonprogo Regency has reported 19 HIV-AIDS cases in 2025, with a notable number detected among residents outside the Kulonprogo health Facility (Faskes). Health officials are emphasizing the critical role of risky sexual behaviors, especially among men who have sex with men, in the transmission of the virus.

Rising HIV-AIDS Cases Linked to Risky Sexual Behavior

Arif Mustofa,Head of Disease Prevention and Control Division (P2P) at the Kulonprogo Health Office,highlighted that male-to-male sexual contact accounts for a significant percentage (10-15%) of HIV-AIDS transmissions. While the percentage may seem small, the increasing trend and higher risk associated with anal sex are causes for concern.

Did You Know? The CDC estimates that approximately 1.2 million peopel in the United States had HIV at the end of 2021. CDC HIV Statistics

Other contributing factors to HIV-AIDS transmission in Kulonprogo include transvestism, tuberculosis (TB), sexually transmitted infections (STIs), mother-to-child transmission, and sex work.

Geographic Distribution of Cases

The distribution of HIV-AIDS cases varies across Kulonprogo. Eight areas-Galur, Panjatan, lendah, Pengasih, Samigaluh, Temon, and Sentolo-reported one to two cases each. Wates recorded the highest number, with four cases.

Location Number of Cases
Galur 1-2
panjatan 1-2
Lendah 1-2
pengasih 1-2
samigaluh 1-2
Temon 1-2
Sentolo 1-2
Wates 4

Prevention and Mitigation Efforts

Health officials are working to curb the spread of HIV-AIDS. In 2024, Kulonprogo saw 49 cases, and efforts are underway to prevent a similar increase in 2025. The primary mode of transmission remains heterosexual contact.

The Kulonprogo Health Office is implementing various strategies, including primary prevention to stop new infections. Free condoms are distributed through the AIDS Commission,and HIV testing and ARV therapy are available in communities and schools for pregnant women to prevent mother-to-child transmission.

Pro Tip: Early detection is crucial. Voluntary HIV testing is available at health facilities. Treatment and assistance are provided to those who test positive.

Arif Mustofa urged the community to take proactive steps to prevent HIV-AIDS, such as avoiding multiple sexual partners, using condoms during sex with positive individuals, and refraining from sharing drug syringes.

Call to action

The Kulonprogo Health Office emphasizes the importance of community involvement in preventing the spread of HIV-AIDS. By understanding the role of risky behaviors and taking preventive measures, residents can protect themselves and others.

What steps can communities take to further reduce HIV transmission rates? How can individuals be encouraged to get tested and seek treatment?

Understanding HIV-AIDS: A Global Perspective

HIV-AIDS remains a significant global health issue. While advancements in treatment have greatly improved the quality of life for those living with HIV, prevention remains key to controlling the epidemic. UNAIDS reports that in 2022, 39 million people globally were living with HIV. UNAIDS Fact Sheet

Education, access to testing, and affordable treatment are crucial components of a comprehensive HIV-AIDS strategy. Addressing stigma and discrimination is also essential to encourage people to get tested and seek care.

Frequently Asked Questions About HIV-AIDS


Disclaimer: This article provides general information and should not be considered medical advice.Consult with a healthcare professional for personalized guidance.

Share this article to raise awareness about HIV-AIDS prevention! What other topics related to public health would you like to see covered?

0 comments
0 FacebookTwitterPinterestEmail
World

Trump Open to Rejoining WHO: US Membership Under Consideration

by Chief editor of world-today-news.com
written by Chief editor of world-today-news.com

Trump Signals Potential Return to ‍WHO Amid Funding Concerns

Jakarta – In a surprising turn of events, former ‌US ⁢President⁢ Donald Trump ⁤has hinted​ at the possibility of rejoining ‌the⁢ World Health ⁣Association (WHO), just‌ days after⁤ announcing the US’s withdrawal from the global health‍ body. Trump’s decision to⁣ leave the WHO, which he ⁢criticized for its handling of the COVID-19 pandemic ‌and ⁣other health crises, was met with widespread concern.

Speaking at a rally in Las Vegas, Trump stated, “Maybe we’ll⁢ consider doing⁤ it again, I don’t know. Maybe we will. They have to clean​ it up.” This statement,‌ reported by Reuters, comes as the US is set to officially exit the WHO on January 22, 2026. ⁣The withdrawal was announced ⁣shortly after Trump was sworn in ⁣for his second term in the White⁣ House.‍ ‍

The US has been the WHO’s ​largest financial contributor, providing​ approximately 18% of its funding.The organization’s latest two-year budget for ⁣2024-2025 stands at $6.8 billion.Trump ‍expressed dissatisfaction ⁣with ⁢the funding ⁣disparity, noting that the US contributes more than ⁢China, despite China’s⁣ substantially​ larger population. ⁤

Experts warn that a US exit‍ could ​have severe consequences for global health‍ initiatives. Programs addressing​ tuberculosis, the world’s deadliest infectious disease, as ‌well as HIV-AIDS and other health emergencies, could be jeopardized. The withdrawal order signed by Trump also halts negotiations on the WHO​ pandemic agreement⁣ and mandates the redeployment of US personnel working with the organization.

Key ‌Points at a Glance ⁤

|⁣ Aspect ‍ ⁣ ⁢| Details ‌ ​ ‍⁤ ⁤ ‍ ‍ ​ ⁢ ⁤ ​ ⁣ ⁢ ⁣|
|————————–|—————————————————————————–| ⁤
| US Withdrawal Date ⁢ ‌| January 22, 2026⁤ ⁢ ‍ ‍ ⁣ ⁤ ‌⁢ ⁤ ⁤ ⁣ |
| WHO Budget (2024-2025) | $6.8 billion ​ ⁢ ⁤ ⁤ ​​ ​ ‌⁣ ⁢ ⁤ ⁢ ⁢ |
| US Contribution ⁣ ⁣ | 18% of total ​funding ​ ⁣ ‍ ⁣ ⁢ ⁤ ⁢ ​ ⁢ ​ ⁢​ ‍ ⁤ ​ | ‌
| Potential Impact ⁣ ⁣ |‌ Jeopardizes ⁤programs for tuberculosis, HIV-AIDS, and health emergencies |

As the world watches this unfolding progress,‍ the⁢ question remains: Will the US rejoin the WHO, or will its departure mark a meaningful ⁤shift in global health ⁢governance? For more insights ​on ⁤the WHO’s role‍ in global‌ health, visit​ World​ Health Organization. ⁣

What are your thoughts on this potential reversal? Share‌ your opinions and join the conversation below.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com